Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Solution preparation containing carbocisteine for atomizing inhalation and preparation method thereof

A carbocisteine ​​and atomized inhalation technology, which is applied in the field of carbocisteine ​​atomized inhalation solution preparation and its preparation, can solve the problems of large oral liquid intake, excessive liver and kidney metabolism, organ damage, etc. Safety, simple production process, quick effect

Inactive Publication Date: 2019-05-14
BEIJING INCREASE INNOVATIVE DRUG RESEARCH CO LTD
View PDF6 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The carbocisteine ​​is salted with sodium hydroxide solution, dissolved in water, then added with antioxidant, solution stabilizer combination and flavoring agent, and then prepared after stirring, constant volume, filtration, canning and sterilization, but oral administration If the dosage of the liquid is large, the metabolism of the liver and kidney is more, it is easy to cause organ damage, the amount of medicine reaching the target organ is less, and the onset of effect is slower

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Solution preparation containing carbocisteine for atomizing inhalation and preparation method thereof
  • Solution preparation containing carbocisteine for atomizing inhalation and preparation method thereof
  • Solution preparation containing carbocisteine for atomizing inhalation and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1: single dose carbocisteine ​​nebulized inhalation solution preparation

[0032] prescription:

[0033] Carbocisteine ​​20mg

[0034] Edetate Disodium 0.1mg

[0035] Appropriate amount of sodium hydroxide, adjust the pH to 5

Embodiment 2

[0036] Embodiment 2: single dose carbocisteine ​​nebulized inhalation solution preparation

[0037] prescription:

[0038] Carbocisteine ​​40mg

[0039] Edetate Disodium 0.5mg

[0040] Appropriate amount of sodium hydroxide, adjust the pH to 6

Embodiment 3

[0041] Embodiment 3: Single dose carbocisteine ​​nebulized inhalation solution preparation

[0042] prescription:

[0043] Carbocisteine ​​50mg

[0044] Edetate Disodium 2mg

[0045] Appropriate amount of sodium hydroxide, adjust the pH to 6

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a solution preparation containing carbocisteine for atomizing inhalation and a preparation method thereof. The solution preparation containing one dose of carbocisteine for atomizing inhalation is prepared from 20-120 mg of carbocisteine or salts and / or hydrates thereof (calculated as free carbocisteine), 0.1-5 mg of a metal complexing agent and a proper volume of a pH modifier and water for injection. The prepared solution preparation containing carbocisteine for atomizing inhalation has the advantages of high efficiency, low toxicity, good stability and high safety, and particularly reduces the medicinal toxicity in the liver and kidney of a patient greatly.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and in particular relates to a carbocisteine ​​solution preparation for atomized inhalation and a preparation method thereof. Background technique [0002] Due to factors such as dense population, large number of smokers and environmental pollution, the morbidity and mortality of respiratory diseases have remained high in recent years. The cause of death (excluding tumors) rose from 10th in 1970 to 4th (chronic obstructive pulmonary disease) and 8th (pneumonia, influenza and upper respiratory tract infection) in 1991, while respiratory diseases in my country The incidence rate of the disease all accounts for the first of many diseases in any age group. This problem has attracted people's attention day by day, so the development of drugs for treating respiratory diseases (respiratory drugs for short) has also become an important research and development field of drug research. [0003] C...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/72A61K47/18A61K47/02A61K31/198A61P11/00A61P11/10
CPCA61K9/0073A61K9/08A61K47/183A61K47/02A61K31/198A61P11/00A61P11/10A61K9/0078A61P11/08A61K9/12
Inventor 张保献胡杰
Owner BEIJING INCREASE INNOVATIVE DRUG RESEARCH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com